Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial

Summary: Background: Novartis Access is a Novartis programme that offers a portfolio of non-communicable disease medicines at a wholesale price of US$1 per treatment per month in low-income and middle-income countries. We evaluated the effect of Novartis Access in Kenya, the first country to receive...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter C Rockers, ScD (Author), Richard O Laing, ProfMD (Author), Paul G Ashigbie, DrPH (Author), Monica A Onyango, PhD (Author), Carol K Mukiira, MA (Author), Veronika J Wirtz, PhD (Author)
Format: Book
Published: Elsevier, 2019-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available